ABOUT THE NPS CONFERENCE SERIES
In recent years, there has been a dramatic increase in the number of new psychoactive substances (NPS) detected across the world. This phenomenon has largely been driven by globalisation, the internet, and rapid technological advancements, and it poses numerous challenges in terms of detecting, measuring, and monitoring these substances; understanding patterns of use and associated harms; and developing appropriate public health responses.
Faced with the many challenges posed by NPS, the International Society for the Study of Emerging Drugs (ISSED) strives to strengthen multidisciplinary and international collaboration, enhance knowledge, and improve the quality of information-sharing in this complex area. In this context, the NPS conference series, which started in Budapest in 2012, has become the major international event on NPS, attracting hundreds of participants worldwide.
It is jointly organised by the Society for the Study of Emerging Drugs (ISSED), in partnership with the United Nations Office on Drugs and Crime (UNODC), the World Anti-Doping Agency (WADA), the European Union Drug Agency (EUDA), the University of Trento and the University of Hertfordshire.
WE ARE HYBRID
ATTEND THE CONFERENCE FROM ANYWHERE AT ANYTIME
Join the conference via live streaming. You can also access most of the presentations after the conference and be able to download the slides and original posters.
NPS ARCHIVE IN YOUR HAND
Develop your professional skill sets by accessing over 500 lectures in our NPS Archive.
You can use any type of computers/laptops, this includes Windows, Mac as long as you can watch YouTube video without any problem.
Most of the mobile devices (iPad, Android Tablets, Smartphones) will be able to access online streaming with a stable WIFI connect, the quality of the streaming is determined by the speed of the internet.
KEEP IN TOUCH
Sign up to our newsletter to receive the latest news and events of NPS
MAIN OBJECTIVES
• Improving understanding of clinical treatment and management of NPS use
• Exploring policy and legislative responses to NPS
• Developing innovative prevention measures for vulnerable individuals
• Sharing analytical approaches to NPS detection and identification
• Understanding the pharmacology and effects of NPS
• Identifying public health implications of NPS
• Exploring motivations and socio-cultural factors underlying NPS use
• Networking and providing the opportunity to meet leading experts in the field
Scientific Committee:
Ornella Corazza (Chair)
University of Hertfordshire, UK
University of Trento, Italy
Ana Gallegos
European Union Drugs Agency (EUDA)
Olivier Rabin
World Anti-Doping Agency (WADA)
Amine Benyamina
Université Paris-Saclay, France
Vidya Mohamed-Ali
University College London, UK
Andres Roman-Urrestarazu
University of Cambridge, UK
Justice Tettey
United Nations Office on Drugs and Crime (UNODC)
Giovanni Martinotti
University of Chieti-Pescara, Italy
Francesco Botre’
University of Florence, Italy
Gianluca Esposito
University of Trento, Italy
University of Elche, Spain
Darshan Singh
Universiti Sains Malaysia, Malaysia
Saul Saucedo
Pan America Anti-Doping
Jan Ramaekers
University of Maastricht, Netherlands
Vincenzo Abbate
King’s College London, UK
Matteo Marti
University of Ferrara, Italy
Lambros Lazuras
University of Lincoln, UK



















































































































